Abstract
To the Editor: The Cutaneous Dermatomyositis Disease Activity and Severity Index (CDASI) is a reliable, validated outcome measure that correlates with quality of life and disease progression.1 Whereas a decrease in activity score correlates well with an improvement in skin disease, the CDASI activity (CDASI-A) score has not been used to quantitatively measure a significant increase in skin activity or a cutaneous flare.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
